Evidence map›Paper›PMID 37397524›Full record

ArticleGenes & diseases2023

Integrative multi-platform meta-analysis of hepatocellular carcinoma gene expression profiles for identifying prognostic and diagnostic biomarkers.

Maryam Gholizadeh, Morteza Hadizadeh, Seyed Reza Mazlooman, Saeid Eslami, Sadegh Raoufi, Marziye Farsimadan, Maryam Rashidifar, Marek Drozdzik, Mehrnaz Mehrabani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes & diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maryam GholizadehDepartment of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 91388-13944, Iran.
Morteza HadizadehPhysiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman 7616913555, Iran.
Seyed Reza MazloomanDepartment of Computer Engineering, Central Tehran Branch, Islamic Azad University, Tehran 1477893780, Iran.
Saeid EslamiDepartment of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 91388-13944, Iran.
Sadegh RaoufiModeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman 7616913555, Iran.
Marziye FarsimadanDepartment of Biology, Faculty of Sciences, University of Guilan, Rasht 13111-41937, Iran.
Maryam RashidifarDepartment of Plant Biotechnology, Faculty of Life Science and Biotechnology, Shahid Beheshti University, Tehran 198396-3113, Iran.
Marek DrozdzikDepartment of Experimental and Clinical Pharmacology, Pomeranian Medical University, Szczecin 70-111, Poland.
Mehrnaz MehrabaniPhysiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman 7616913555, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37397524
PMCPMC10311049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.